28.20
0.00
(0.00%)
At close: April 15 at 8:00:32 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 5 | 5 |
| Avg. Estimate | 724.69M | 657.8M | 2.83B | 3.07B |
| Low Estimate | 643.37M | 654M | 2.44B | 2.68B |
| High Estimate | 806M | 661.6M | 3B | 3.3B |
| Year Ago Sales | 568M | 537M | 2.26B | 2.83B |
| Sales Growth (year/est) | 27.59% | 22.50% | 25.15% | 8.36% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RPD.MU | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 10/25/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 8/14/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 7/11/2024 |
| Downgrade | UBS: Buy to Neutral | 6/3/2024 |
| Maintains | B of A Securities: Buy to Buy | 4/12/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 2/20/2024 |
Related Tickers
B9A.F BioArctic AB (publ)
16.79
+12.46%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
HQ1.MU Oruka Therapeutics Inc. R
7.05
+6.02%
2HA.F Spero Therapeutics, Inc.
0.6170
+16.64%
P0F.F Egetis Therapeutics AB (publ)
0.2955
-4.68%
ICY.HA Incyte Corp
52.14
+1.76%
7PO.F Poxel S.A.
0.4510
-11.39%
PROT Proteonomix, Inc.
0.0000
0.00%
05Y.MU Vivoryon Therapeutics NV
1.7440
-4.49%
BT3.BE Lineage Cell Therapeutics Inc
0.3800
-5.47%